A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT06789302 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06789302
Sponsor: Global Institute of Stem Cell Therapy and Research
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2025-12-01
Primary completion: 2028-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.